LaVerne H. Council
Known title: DirectorCIK: 0001788616
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
CNXC Faces Scrutiny Over Loss Guidance and Dividend Policy. Recent articles question whether Concentrix's loss-making guidance and ongoing dividend payouts are changing its investment case. The stock is also being highlighted in broader business services industry outlooks alongside peers like ABM and Sodexo. With the share price trading near its 52-week low, these reports add context to the current valuation debate.
Transaction History
| CNMD | ▲ Buy | Option Exercise | 668 | $0 | 6/2/2026 | View on chart |
| CNXC | ▲ Buy | Grant | 7,701 | $0 | 3/25/2026 | View on chart |
| CNMD | ▲ Buy | Option Exercise | 479 | $0 | 6/3/2025 | View on chart |
| CNXC | ▲ Buy | Grant | 3,873 | $0 | 3/25/2025 | View on chart |
| CNMD | ▲ Buy | Option Exercise | 302 | $0 | 5/31/2024 | View on chart |
| CNXC | ▲ Buy | Grant | 2,780 | $0 | 3/21/2024 | View on chart |
| CNMD | ▲ Buy | Option Exercise | 335 | $0 | 6/1/2023 | View on chart |
| CNXC | ▲ Buy | Grant | 1,482 | $0 | 3/23/2023 | View on chart |
| CNMD | ▲ Buy | Option Exercise | 812 | $0 | 6/1/2022 | View on chart |
| CNXC | ▲ Buy | Grant | 750 | $0 | 3/22/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
No CNMD-Specific News in Past 7 Days
The only news article in the past week references Henry Schein (HSIC), not CONMED itself. This appears to be a sector comparison piece tracking HSIC's performance since its last earnings release. There is no recent CNMD-specific news to report. Market participants seeking updates on CONMED's operations, financial results, or strategic developments will need to look beyond this seven-day window.
No CNMD-Specific News in Past 7 Days. The only news article in the past week references Henry Schein (HSIC), not CONMED itself. This appears to be a sector comparison piece tracking HSIC's performance since its last earnings release. There is no recent CNMD-specific news to report. Market participants seeking updates on CONMED's operations, financial results, or strategic developments will need to look beyond this seven-day window.